Risk of Acute Pancreatitis and Biliary Events After Initiation of Incretin-Based Medications in Patients With Type 2 Diabetes
In patients with T2D, GLP-1RAs and DPP-4is were associated with a small increase in risk of biliary disease, but not of AP, compared with SGLT2is.
Authors
- Elisabetta Patorno (ORCID: https://orcid.org/0000-0002-8809-9898)
- Janinne Ortega-Montiel (ORCID: https://orcid.org/0000-0001-8196-6648)
- Helen Tesfaye (ORCID: https://orcid.org/0000-0002-6264-2813)
- Deborah J. Wexler (ORCID: https://orcid.org/0000-0001-6979-402X)
- Julie M. Paik (ORCID: https://orcid.org/0000-0002-1315-5445)
- Yichen E Fang (ORCID: https://orcid.org/0000-0001-7323-2716)
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- VA Boston Healthcare System (US)
- Massachusetts General Hospital (US)
- VA New England Healthcare System (US)
Publication Details
- Journal
- Diabetes Care
- Published
- 2025-10-27
- DOI
- https://doi.org/10.2337/dc25-1840
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.29